Company / Free Cash Flow per Share
CAPRICOR THERAPEUTICS, INC. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.27
FY2025
5-year range
-$1.27 / $0.12
FY2021-FY2025
Trend
-40.4%
vs FY2024
Sector context
#113 of 193
Health Care
What the data says
At $-1.27, CAPRICOR THERAPEUTICS, INC.'s free cash flow per share ranks #113 of 193 in the Health Care sector. Free Cash Flow per Share has declined for 3 consecutive years, from $0.12 in FY2022 to $-1.27 in FY2025.
Based on SEC 10-K filings.
-1.27 in FY2025.
Declined from $-0.86 to $-1.27 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#113 of 193 in Health CareTop 59% of 193This company -$1.27 Sector average -$19.72
▼
+93.6% above sector average
Key checks
Key Insights
- CAPRICOR THERAPEUTICS, INC.'s free cash flow per share has declined for 3 consecutive years.
- In FY2025, free cash flow per share decreased 40.4% year-over-year.
- Ranks #113 out of 193 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.27 | -40.4% |
| FY2024 | -$0.90 | -4.5% |
| FY2023 | -$0.86 | -847.7% |
| FY2022 | $0.12 | +115.5% |
| FY2021 | -$0.74 | -44.5% |
| FY2020 | -$0.52 | +88.6% |
| FY2019 | -$4.52 | -900.0% |
| FY2018 | -$0.45 | +16.8% |
| FY2017 | -$0.54 | +20.7% |
| FY2016 | -$0.68 | -1.6% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026